Publications by authors named "Daniel Mathews"

Claim this Profile
A
A Case of Acute Renal Infarct Secondary to Protein S Deficiency.
Daniel Sam Mathews, Ninoo George, Ranjit Jeyasekharan

Indian J Nephrol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.
Erica M Richards, Daniel C Mathews, David A Luckenbaugh, Dawn F Ionescu, Rodrigo Machado-Vieira

Psychopharmacology (Berl)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants.
Mark J Niciu, Daniel C Mathews, Allison C Nugent, Dawn F Ionescu, Maura L Furey

Depress Anxiety· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers in mood disorders research: developing new and improved therapeutics.
Mark J Niciu, Daniel C Mathews, Dawn F Ionescu, Erica M Richards, Maura L Furey

Rev Psiquiatr Clin· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.
Mark J Niciu, David A Luckenbaugh, Dawn F Ionescu, Daniel C Mathews, Erica M Richards

Biol Psychiatry· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part I: major depressive disorder.
Mark J Niciu, Dawn F Ionescu, Daniel C Mathews, Erica M Richards, Carlos A Zarate

CNS Spectr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second messenger/signal transduction pathways in major mood disorders: moving from membrane to mechanism of action, part II: bipolar disorder.
Mark J Niciu, Dawn F Ionescu, Daniel C Mathews, Erica M Richards, Carlos A Zarate

CNS Spectr· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression.
Carlos A Zarate, Daniel Mathews, Lobna Ibrahim, Jose Franco Chaves, Craig Marquardt

Biol Psychiatry· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine.
Mary C Zeng, Mark J Niciu, David A Luckenbaugh, Dawn F Ionescu, Daniel C Mathews

Biol Psychiatry· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human biomarkers of rapid antidepressant effects.
Carlos A Zarate, Daniel C Mathews, Maura L Furey

Biol Psychiatry· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of ketamine and related compounds for depression.
Daniel C Mathews, Carlos A Zarate

J Clin Psychiatry· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurobiology of anxious depression: a review.
Dawn F Ionescu, Mark J Niciu, Daniel C Mathews, Erica M Richards, Carlos A Zarate

Depress Anxiety· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.
Gonzalo Laje, Níall Lally, Daniel Mathews, Nancy Brutsche, Anat Chemerinski

Biol Psychiatry· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.
David A Luckenbaugh, Lobna Ibrahim, Nancy Brutsche, Jose Franco-Chaves, Daniel Mathews

Bipolar Disord· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date.
Daniel C Mathews, Ioline D Henter, Carlos A Zarate

Drugs· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are dopaminergic genes involved in a predisposition to pathological aggression? Hypothesizing the importance of "super normal controls" in psychiatricgenetic research of complex behavioral disorders.
Thomas J H Chen, Kenneth Blum, Daniel Mathews, Larry Fisher, Nancy Schnautz

Med Hypotheses· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis